Cell-penetrating Peptide-biodrug Strategy for Oral and Nasal Delivery: Review of Recent Findings

Journal of Experimental and Clinical Medicine

Volumn 4, Issue 4, 2012, Pages 198-202

  Khafagy, El Sayed ^a   Kamei, Noriyasu ^b   Takeda Morishita, Mariko ^b  

^a Suez Canal University   (Egypt)

^b KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cell penetrating peptides; Drug delivery; Pharmaceutical strategy; Therapeutic peptides

Indexed keywords

BIOLOGICAL PRODUCT; CELL PENETRATING PEPTIDE; EXENDIN 4; GALLIUM 68; GASTRIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; OLIGOARGININE; PENETRATIN; RECOMBINANT BETA INTERFERON; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

CHEMICAL MODIFICATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SAFETY; DRUG TRANSPORT; FEASIBILITY STUDY; INTESTINE EPITHELIUM; INTRANASAL DRUG ADMINISTRATION; MOLECULAR IMAGING; MOLECULAR INTERACTION; NONHUMAN; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SURFACE PLASMON RESONANCE;

EID: 84865739024     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2012.06.013     Document Type: Review

References (55)

1. Flower D.R. Advances in predicting and manipulating the immunogenicity of biotherapeutics and vaccines. BioDrugs 2009, 23:231-240.
2. Frokjaer S., Otez D.D. Protein drug stability: a formulation challenge. Nat Rev Drug Discov 2005, 4:298-306.
3. El-S Khafagy, Morishita M., Onuki Y., Takayama K. Current challenges in noninvasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007, 59:1521-1546.
4. Mustata G., Dinh S.M. Approaches to oral drug delivery for challenging molecules. Crit Rev Ther Drug Carrier Syst 2006, 23:1111-1135.
5. Owens D.R. New horizons-alternative routes for insulin therapy. Nat Rev Drug Discov 2002, 1:529-540.
6. Cefalu W.T. Concept, strategies, and feasibility of noninvensive insulin delivery. Diabetes Care 2004, 27:239-246.
7. Morishita M., Peppas N.A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov Today 2006, 11:905-910.
8. Goldberg M., Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2003, 2:289-295.
9. Colombo P., Sonvico F., Colombo G., Bettini R. Novel platforms for oral drug delivery. Pharm Res 2009, 26:601-611.
10. Shah R.B., Ahsan F., Khan M.A. Oral delivery of proteins: progress and prognostication. Crit Rev Ther Drug Carrier Syst 2002, 19:135-169.
11. Costantino H.R., Illum L., Brandt G., Johnson P.H., Quay S.C. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 2007, 337:1-24.
12. Gangwar S., Pauletti G.M., Wang B., Siahaan T.J., Stella V.J., Borchardt R.T. Prodrug strategies to enhance the intestinal absorption of peptides. Drug Discov Today 1997, 2:148-155.
13. Mizuma T., Koyanagi A., Awazu S. Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs. Biochim Biophys Acta 2000, 1475:90-98.
14. Hichens M. A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology. Drug Metab Rev 1983, 14:77-98.
15. Hashimoto M., Takada K., Kiso Y., Muranishi S. Synthesis of palmitoyl derivatives of insulin and their biological activities. Pharm Res 1989, 6:171-176.
16. Calceti P., Salmaso S., Walker G., Bernkop-Schnürch A. Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur J Pharm Sci 2004, 22:315-323.
17. Basu A., Yang K., Wang M., Liu S., Chintala R., Palm T., Zhao H., et al. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Bioconjugate Chem 2006, 17:618-630.
18. Wang J., Chow D., Heiati H., Shen W.C. Reversible lipidization for the oral delivery of salmon calcitonin. J Control Release 2003, 26:369-380.
19. Russell-Jones G.J. Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium. J Drug Target 2004, 12:113-123.
20. Hwa Kim S. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Release 2005, 103:625-634.
21. Lim C.J., Shen W.C. Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs. J Control Release 2005, 106:273-286.
22. Bai Y., Ann D.K., Shen W.C. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci USA 2005, 102:7292-7296.
23. Goto T., Morishita M., Nishimura K., Nakanishi M., Kato A., Ehara J., Takayama K. Novel mucosal insulin delivery systems based on fusogenic liposomes. Pharm Res 2006, 23:384-391.
24. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003, 86:235-242.
25. Brayden D.J., Jepson M.A., Baird A.W. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today 2005, 10:1145-1157.
26. Shakweh M., Besnard M., Nicolas V., Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm 2005, 61:1-13.
27. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997, 14:1568-1573.
28. Ye S., Wang C., Liu X., Tong Z., Ren B., Zeng F. New loading process and release properties of insulin from polysaccharide microcapsules fabricated through layer-by-layer assembly. J Control Release 2006, 112:79-87.
29. Watnasirichaikul S., Davies N.M., Rades T., Tucker I.G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm Res 2000, 17:684-689.
30. Wang L.Y., Gu Y.H., Su Z.G., Ma G.H. Preparation and improvement of release behavior of chitosan microspheres containing insulin. Int J Pharm 2006, 311:187-195.
31. Garcia-fuentes M., Prego C., Torres D., Alonso M.J. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci 2005, 25:133-143.
32. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002, 245:1-7.
33. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001, 276:5836-5840.
34. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994, 269:10444-10450.
35. Nakase I., Takeuchi T., Tanaka G., Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv Drug Deliv Rev 2008, 60:598-607.
36. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 2000, 56:318-325.
37. Massodi I., Bidwell G.L., Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release 2005, 108:396-408.
38. Kleemann E., Neu M., Jekel N., Fink L., Schmehl T., Gessler T., Seeger W., et al. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 2005, 109:299-316.
39. El-Andaloussi S., Guterstam P., Langel ü. Assessing the delivery efficacy and internalization route of cell-penetrating peptides. Nat Protoc 2007, 2:2043-2047.
40. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 2003, 100:1972-1977.
41. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006, 58:1532-1555.
42. Morishita M., Kamei N., Ehara J., Isowa K., Takayama K. A novel approach using functional peptides for efficient intestinal absorption of insulin. J Control Release 2007, 118:177-184.
43. Kamei N., Morishita M., Eda Y., Ida N., Nishio R., Takayama K. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. J Control Release 2008, 132:21-25.
44. El-S Khafagy, Morishita M., Kamei N., Eda Y., Ikeno Y., Takayama K. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharm 2009, 381:49-55.
45. El-S Khafagy, Morishita M., Isowa K., Imai J., Takayama K. Effect of c ell-penetrating peptides on the nasal absorption of insulin. J Control Release 2009, 133:103-108.
46. Kamei N., Morishita M., Ehara J., Takayama K. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery. J Control Release 2008, 131:94-99.
47. Kamei N., Morishita M., Takayama K. Importance of intermolecualr interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides. J Control Release 2009, 136:179-186.
48. El-S Khafagy, Morishita M., Takayama K. The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides. Int J Pharm 2010, 388:209-212.
49. Swanson J.A., Watts C. Macropinocytosis. Trends Cell Biol 1995, 5:424-428.
50. Falcone S., Cocucci E., Podini P., Kirchhausen T., Clementi E., Meldolesi J. Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci 2006, 119:4758-4769.
51. Richard J.P., Melikov K., Vives V., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003, 278:585-590.
52. Kaplan I.M., Wadia J.S., Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005, 102:247-253.
53. Ohira T., Okuma T., Matsuoka T., Wada Y., Nakamura K., Watanabe Y., Inoue Y. FDG-microPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits. Cardiovasc Interv Radiol 2009, 32:114-120.
54. Okuma T., Matsuoka T., Okamura T., Wada Y., Yamamoto A., Oyama Y., Koyama K., et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 2006, 47:1351-1358.
55. Kamei N., Morishita M., Kanayama Y., Hasegawa K., Nishimura M., Hayashinaka E., Wada Y., et al. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. J Control Release 2010, 146:16-22.